LOC387715, smoking and their prognostic impact on visual functional status in age-related macular degeneration - The Muenster Aging and Retina Study (MARS) cohort

Ophthalmic Epidemiology

Volumn 15, Issue 3, 2008, Pages 148-154

  Neuner, Bruno ^a   Wellmann, Juergen ^a   Dasch, Burkhard ^a   Dietzel, Martha ^a,b   Farwick, Astrid ^a   Stoll, Monika ^a   Pauleikhoff, Daniel ^b   Hense, Hans Werner ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

Age related maculopathy; Genes; Prognosis; Smoking; Visual functional status

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE; GENOTYPE; HOMOZYGOSITY; HUMAN; LOC387715 GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SMOKING CESSATION; VISION;

AGED; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HOMOZYGOTE; HUMANS; LINEAR MODELS; MACULAR DEGENERATION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; VARIATION (GENETICS); VISION;

EID: 45749143929     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580802105830     Document Type: Article

References (26)

1. Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration - Emerging pathogenetic and therapeutic concepts. Ann Med. 2006; 38(7):450-471.
2. Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: A review of progress to date. Surv Ophthalmol. 2006; 51(4):316-363.
3. Scholl HP, Fleckenstein M, Charbel IP et al. An update on the genetics of age-related macular degeneration. Mol Vis. 2007; 13():196-205.
4. Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005; 308(5720):419-421.
5. Ross RJ, Bojanowski CM, Wang JJ et al. The LOC387715 polymorphism and age-related macular degeneration: Replication in three case-control samples. Invest Ophthalmol Vis Sci. 2007; 48(3):1128-1132.
6. Tan JS, Mitchell P, Kifley A et al. Smoking and the long-term incidence of age-related macular degeneration: The Blue Mountains Eye Study. Arch Ophthalmol. 2007; 125(8):1089-1095.
7. Thornton J, Edwards R, Mitchell P et al. Smoking and agerelated macular degeneration: A review of association. Eye. 2005; 19(9):935-944.
8. Weale R. Smoking and age-related maculopathies. Lancet. 2006; 368(9543):1235-1236.
9. Chakravarthy U, Stevenson M. Self-reported visual functioning and quality of life in age-related macular degeneration. Curr Opin Ophthalmol. 2005; 16(3):179-183.
10. Mitchell J, Bradley C. Quality of life in age-related macular degeneration: A review of the literature. Health Qual Life Outcomes. 2006; 4:97.
11. Schmidt S, Hauser MA, Scott WK et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet. 2006; 78(5):852-864.
12. Dasch B, Fuhs A, Meister A et al. [Association between classic cardiovascular risk factors and age-related maculopathy (ARM) Results of the baseline examination of the Munster Aging and Retina Study (MARS).]. Ophthalmologe. 2005; 102(11):1057-1063.
13. Dasch B, Fuhs A, Behrens T et al. Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Muenster Aging and Retina Study. Arch Ophthalmol. 2005; 123(11):1501-1506.
14. Klaver CC, Assink J, van Leeuwen R et al. Incidence and progression rates of age-related maculopathy: The Rotterdam Study. Invest Ophthalomol Vis Sci. 2001; 42(10):2237-2241.
15. Rivera A, Fisher SA, Fritsche LG et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005; 14(21):3227-3236.
16. Seddon JM, Francis PJ, George S et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA. 2007; 297(16):1793-1800.
17. Schaumberg DA, Hankinson SE, Guo Q et al. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol. 2007; 125(1):55-62.
18. Mangione CM, Lee PP, Gutierrez PR et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001; 119(7):1050-1058.
19. Goetz SM, Stuck AE, Hirschi A et al. [A multidimensional questionnaire as a component of preventive geriatric assessment: Comparison of self-assessment version with the interview version]. Soz Praventivmed. 2000; 45(3):134-146.
20. Fuhs A, Dasch B, Behrens T et al. [Visual function and quality of life in patients with age-related maculopathy:Results of the Munster Age and Retina Study (MARS)]. Klin Monatsbl Augenheilkd. 2005; 222(8):649-654.
21. Frison L, Pocock SJ. Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for design. Stat Med. 1992; 11(13):1685-704.
22. Leffondre K, Abrahamowicz M, Siemiatycki J, Rachet B. Modeling smoking history: A comparison of different approaches. Am J Epidemiol. 2002; 156(9):813-823.
23. Neuner B, Wellmann J, Dasch B et al. Modeling smoking history: A comparison of different approaches in the Mars study on age-related maculopathy. Ann Epidemiol. 2007; 17(8):615-621.
24. SAS. Version 9.1, Cary, NC, USA, 2000.
25. Despriet DD, Klaver CC, Witteman JC et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006; 296(3):301-309.
26. Harrington J, Noble LM, Newman SP. Improving patients' communication with doctors: a systematic review of intervention studies. Patient Educ Couns. 2004; 52(1):7-16.